NCT06116955 - The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy | Biotech Hunter

Enrollment

424

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

January 1, 2024

Conditions

Bronchoscopy

Interventions

DRUG

Midazolam and sufentanil

Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with midazolam combined with sufentani.

DRUG

Midazolam, sufentanil and propofol

Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with midazolam and sufentani combined with propofol.

DRUG

Remazolam and sufentanil.

Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with remazolam combined with sufentani.

DRUG

Remazolam, sufentanil and propofol

Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with remazolam and sufentani combined with propofol.

Trial Locations (1)

Affiliated Hospital of Qingdao University, Shandong

All Listed Sponsors

lead

The Affiliated Hospital of Qingdao University

OTHER